Erythromycin and Pitavastatin Interaction

Drug interaction information between Erythromycin and Pitavastatin.

Erythromycin and Pitavastatin have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Erythromycin and Pitavastatin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Erythromycin

Macrolide Antibiotic

Drug B

Pitavastatin

HMG-CoA Reductase Inhibitor (Statin)

How They Interact

Erythromycin slows down how the body processes pitavastatin, which leads to higher amounts of the drug in your system. Having too much pitavastatin in the blood can cause severe muscle breakdown.

FDA Label Information

Erythromycin Clinical Impact: Erythromycin significantly increases pitavastatin exposure and increases the risk of myopathy and rhabdomyolysis. Intervention: In patients taking erythromycin, do not exceed pitavastatin tablets 1 mg once daily [see Dosage and Administration ( 2.4 )].

Pitavastatin Also Interacts With

View all Pitavastatin interactions →

Frequently Asked Questions

What SPL severity band is on file for Erythromycin + Pitavastatin?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Erythromycin has 63 labeled pairs on file vs Pitavastatin's 9. In the major band specifically: Erythromycin has 4 (also Eplerenone, Risperidone, Sildenafil); Pitavastatin has 3 (also Cyclosporine, Rifampin).

What mechanism field is on file for Erythromycin and Pitavastatin?

Erythromycin slows down how the body processes pitavastatin, which leads to higher amounts of the drug in your system. Having too much pitavastatin in the blood can cause severe muscle breakdown.

Erythromycin carries more major-labeled pairs than Pitavastatin

SPL source-record counts only. This page's band is major · classes on file: Erythromycin (Macrolide Antibiotic); Pitavastatin (HMG-CoA Reductase Inhibitor (Statin)).

Erythromycin has 4 major-labeled pairs vs Pitavastatin's 3.

Erythromycin

4 major · 6 moderate · 53 minor · 63 total

Pitavastatin

3 major · 4 moderate · 2 minor · 9 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.